AIkido Pharma (AIKI) Announces Withdrawal of S-1 Registration Statement
- Dow ends at record high after upbeat jobless claims report
- PayPal (PYPL) Gains After Topping Q1 and Guidance Expectations, Crypto Seen as a Key Growth Driver Going Forward
- Square (SQ) Tops Q1 EPS by 25c
- Fed's Kaplan wants taper talk 'sooner rather than later'
- U.S. weekly jobless claims drop below 500,000; layoffs lowest since 2000
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company has withdrawn its S-1 Registration Statement that was previously filed with the U.S. Securities and Exchange Commission ("SEC"). The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the offering described in the Registration Statement.
Anthony Hayes, CEO of AIkido Pharma, stated, "Recent advancements from our research partners and the anticipated publication of testing data for our technology that is expected in the second quarter of this year, reinforce our optimism around the opportunities for our therapeutic drug platform and the future of the Company. Through a series of recent financing transactions, we believe we are sufficiently capitalized to fund research activities that are currently underway and selectively pursue additional emerging opportunities. Given the current market conditions, we determined it is in the best interest of our shareholders to withdraw the registration statement, while staying the course with our approach to developing commercially viable, effective therapies."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Twist Bioscience Corporation (TWST) Misses Q2 EPS by 1c, Revenues Beat; Raises FY21 Revenues Guidance Above Consensus
- Reed's (REED) Announces $7.9 Million Registered Direct Offering
- Syneos Health, Inc. (SYNH) Announces 7M Share Secondary Offering of Common Stock
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!